FDA Investigator Gregory E Beichner
Gregory E Beichner has inspections in 4 countries as of 26 Oct 2023. Gregory E Beichner has collaborated with a combined 1323 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
442
Last Inspection Date:
26 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
France,
Netherlands,
Canada
Co-Investigator(s):
Abdellah El Hajjam,
Alan D Centi,
Andrew I Carr,
Beichner,
Brandi L Garbutt,
Brandon J Brookens,
Brandon M Kurjanowicz,
Brian M Palermo,
Brian R Yaun,
Calvin W Edwards,
Carl E Lovrich,
CDR Michael J Mero,
Chad W Rice,
Chamberlain,
Craig D Zagata,
Crayton Lee,
Crystal A Harlan,
Cynthia L Rakestraw,
Daniel J Mechenbier,
Daniel R Tammariello,
Daniel W Johnson,
Darlene C Plank Turlington,
Dauksism,
David L Pearce,
Deborah G Haney Cozzone,
Deborah H Cozzone,
Dennis L Doupnik,
Dennis R Hock,
Dessa A Antoine,
Edith M Gonzalez,
Erica L Nicoll,
Gale L Glinecki,
Gerald W Kopp,
Gess,
Gladys B Casper,
Gregory E Blichuoy,
Hamiltonl,
Hector J Colon Torres,
Hilary K Wagner,
Iqra Iftikhar,
James M Odonnell,
Jazmine N Brown,
Joseph R Hatcher,
Joseph S Fanelli,
Justin B Holder,
Katelyn Astaub Zamperini,
Kirk A Dymbrowski,
LCDR Susan E Polifko,
LCDR William H Bender,
Linda M Sacco,
LT John M Mastalski,
LTJG Bradley E Benasutti,
Marjorie L Davis,
Mary E Storch,
Mary R Kirker,
Mastalskij,
Maureen A Wentzel,
Melinda L Rice,
Michael J Diskin,
Michael L Casner,
Michael R Klapal,
Michael W Burd,
Myrick,
O'meara,
Sean D Duke,
State Agency,
Tammy M Phillips,
Thomas R Withers,
Thompsonv,
Timothy J Schmidt,
Todd J Maushart,
Tracynda L Davis,
Travers,
Travis R Hunt,
Valeria A Moore,
Van Cliff,
William A Warnick,
William C Brenneman
Gregory E Beichner's Documents
Publish Date | Document Type | Title |
---|---|---|
August, 2008 | EIR | Mars Petcare U.S. - EIR, 2008-08-19 |
February, 2014 | EIR | J.M. Smucker LLC - EIR, 2014-02-06 |
December, 2007 | EIR | Mars Petcare U.S. - EIR, 2007-12-06 |
August, 2021 | EIR | Stello Foods Inc - EIR, 2021-08-03 |
April, 2003 | EIR | Charlie's Specialties, Inc. - EIR, 2003-04-11 |
November, 2011 | EIR | J.M. Smucker LLC - EIR, 2011-11-23 |
April, 2003 | FDA 483 | Charlie's Specialties, Inc. - Form 483, 2003-04-11 |
August, 2021 | FDA 483 | Stello Foods Inc - Form 483, 2021-08-11 |
September, 2009 | FDA 483 | Graham Dairy Supply Inc - Form 483, 2009-09-04 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more